1 1 Dr. Dian Samudra, SpPD 2 Penyakit pembuluh darah muskular, dimana terdapat plak diskrit yg terdiri lemak ekstraselular, lemak intraselular dalam sel busa, serta matriks kolagen jaringan ikat yg diproduksi sel otot polos pembuluh darah Definisi : 3 Diawali oleh pembentukan fatty streak (akumulasi sel busa di sub endotel) fibrous plaque (akumulasi monosit, limfosit, sel busa, sel otot polos) erosi dan ruptur plak disertai trombosis dan perdarahan gejala klinis (infark miokard) 4 Inisiasi dan progresi aterosklerosis
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
1
Dr. Dian Samudra, SpPD
2
Penyakit pembuluh darah muskular, dimanaterdapat plak diskrit yg terdiri lemakekstraselular, lemak intraselular dalam selbusa, serta matriks kolagen jaringan ikat ygdiproduksi sel otot polos pembuluh darah
Definisi :
3
Diawali oleh pembentukan fatty streak(akumulasi sel busa di sub endotel) fibrous plaque (akumulasi monosit, limfosit, sel busa, sel otot polos) erosi dan ruptur plak disertaitrombosis dan perdarahan gejala klinis(infark miokard)
4
Inisiasi dan progresi aterosklerosis
2
5 6
7 8
Faktor Risiko :
1. Diabetes Melitus2. Tekanan darah tinggi3. Kadar kholesterol tinggi4. Tinggi lemak dalam diet5. Obesitas6. Riwayat keluarga dengan penyakit jantung7. Perokok8. Kurang aktivitas
3
9
24.7% 29.9%
Coronary disease7.4%
Atherothrombosis is commonly found in more than one arterial bed in an individual patient*
Cerebrovasculardisease
Peripheral arterial disease (PAD)
3.8% 11.8%
19.2%
* Data from CAPRIE study (n=19,185) Coccheri S. Eur Heart J 1998; 19(suppl): P1268.
• Peripheral arterial disease ( PAD ) - Claudicatio
• DVT ( Deep Vein Trombosis )
12
• Many people with diabetes and PAD do not have any symptoms
• Some people may experience mild leg pain or trouble walking and believe that it’s just sign of getting older
• Classical symptoms :– Leg pain, particularly when walking or exercise,
which disappears after a few minutes of rest– Numbness, tingling, or coldness in the lower
legs or feet– Sore or infections that heal slowly
What are the warning sign of PAD ?
4
13
• PAD, occurs when blood vessels in the leg are narrowed or blocked by fatty deposits, platelets, fibrin, and
other substance on arterial wall
• PAD, increased risk for heart attack and stroke
14
Important signs of chronic arterial insufficiency
• Limb examination (and comparison with the opposite limb) • Hair loss• Poor nail growth (brittle nails)• Dry, scaly, atrophic skin• Dependent rubor• Pallor with leg elevation after 1 minute at 60 degree
• normal color should return in 10 – 15 second• longer than 40 seconds indicated severe ischemia
• Ischemic tissue ulceration • (punched-out painful, with little bleeding) or gangrene
• Absent or diminished femoral or pedal pulses • (especially after exercising the limb)
• Arterial bruits • Additional examination by palpation and auscultation to
detect abnormal aortic aneurysm or bruit
Gey DC et al 2004 ; American Family Physician 69 : 525 - 532
15
Important signs of chronic arterial insufficiency
Gey DC et al 2004 ; American Family Physician 69 : 525 - 532
16
Differential diagnosis of intermitten claudication
Spinal stenosis(pseudoclaudication)
Prolapsed intervertebral disc
Deep vein thrombosisPeripheral neuropathies
Thromboangiitis obliterans(Buerger’s ds)
Restless legs syndrome
Arterial embolusArthritis of the hips
Vascular causesNon vascular causes
Gey DC et al 2004 ; American Family Physician 69 : 525 - 532
5
17 18
How is PAD diagnosed ?
19
Diagnosis :
1.Ankle/brachial index (ABI)
2.Arteriography
3.Cardiac stress testing
4.CT scan
5.Doppler study
6.Intravascular ultrasound (IVUS)
7.Magnetic resonance arteriography (MRA)20
ABI(Ankle Brachial Index)
ADA recommendation :–diabetes : over age of 50
have an ABI test–no-diabetes : younger
than 50 may benefit from testing if they have other PAD risk factors
* The tools required to perform the ABI measurement include a hand-held 5-10 MHz
Doppler probe and a blood pressure cuff24
7
25
• Get help to quit smoking• Aim for an A1c below 7%• Lower blood pressure < 130/80 mmHg• LDL-cholesterol < 100 mg/dl• Taking antiplatelet medicines (Aspirin)• Exercise training for Claudication• Surgical procedure (balloon angioplasty,
artery bypass graft)
How is PAD treated ?
26
Risk-factor modification for the patients with PAD
clopidogrel)Stewart KJ, et al ; N Eng J Med 2002 : 24 : 1941 - 1951
27MWD = maximal walking distance; PFWD = pain-free walking distance; SF-36 = medical outcomes short form 36 questionnaire; WIQ = walkingimpairment questionnaire; A1c = hemoglobin A1c; JNC-VI = Sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; LDL = low-density lipoprotein; MRA = magnetic resonance angiography
Gey DC et al 2004 ; American Family Physician 69 : 525 - 532
28
Segmental blood pressure measurement. A, segmental leg pressures in a normal right extremity (ABI: 115/115 = 1.00) and one with an isolated left iliac artery occlusion (ABI: 70/117 = 0.60).
Horizontal and vertical pressure gradients exist at the thigh. B, segmental leg pressures in a patient with an isolated focal right superficial femoral artery stenosis and a distal left tibial artery occlusion.
J Gen Intern Med 1992;7:91
8
29 30
31
Pharmacotherapy for patients with Claudication
Extensive hemodynamic monitoring for risk of TTP500 mg per day orally
Ticlopidine
Correct dosing is critical; avoid in patients with heart failure; reduce dosing to 50 mg twice per day in patients taking calcium channel blockers; may cause loose stools and gastric upset
100 mg twice per day orally
Cilostazol
May have a small effect on walking ability, but insufficient data to support widespread use
1.2 g per day orally
Pentoxifylline
Fewer side effects than aspirin in the CAPRIE trial; significantly less risk for TTP than ticlopidine
75 mg per day orally
Clopidogrel
Recommended by the American College of Chest Physicians for PAD, but the FDA found insufficient evidence to approve labeling for this indication